Align Technology | ALGN - Assets


Align Technology reported $6.31B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
3M USD 35.44B 2.3B Mar/2026
Align Technology USD 6.31B 80.48M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Bruker USD 6.13B 110.7M Mar/2026
Cardinal Health USD 56.69B 1.39B Mar/2026
Charles River Laboratories USD 7.73B 594.89M Mar/2026
Cooper Companies USD 12.48B 58.1M Mar/2026
CVS Health USD 252.97B 564M Mar/2026
Danaher USD 83.54B 80M Mar/2026
Dentsply International USD 5.23B 200M Mar/2026
Dexcom USD 6.63B 293.4M Mar/2026
Henry Schein USD 11.3B 89M Mar/2026
Idexx Laboratories USD 3.39B 34.74M Mar/2026
Insulet USD 2.99B 203.2M Mar/2026
Integra LifeSciences USD 3.58B 24.28M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
McKesson USD 82.32B 1.87B Mar/2026
Mettler Toledo International USD 3.67B 43.73M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Solventum Corp USD 14.1B 197M Mar/2026
Stryker USD 46.29B 1.55B Mar/2026
Teleflex USD 6.78B 164.24M Mar/2026
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Veeva Systems USD 9.13B 150.22M Mar/2026
Waters USD 24.53B 19.45B Mar/2026
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026
Zoetis USD 15.15B 313M Mar/2026